BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35489606)

  • 1. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
    Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
    Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
    Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.
    Madsen AMR; Schaltz-Buchholzer F; Nielsen S; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Azizi M; Hameed ZN; Johansen IS; Kofoed PE; Krause TG; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Oedegaard ES; Ostenfeld A; Soerensen MK; Wejse C; Netea MG; Aaby P; Benn CS
    J Infect Dis; 2024 Feb; 229(2):384-393. PubMed ID: 37774494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
    Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
    mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
    Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
    Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
    DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
    Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.
    Koekenbier EL; Fohse K; van de Maat JS; Oosterheert JJ; van Nieuwkoop C; Hoogerwerf JJ; Grobusch MP; van den Bosch MAAJ; van de Wijgert JHH; Netea MG; Rosendaal FR; Bonten MJM; Werkhoven CHHV;
    Clin Microbiol Infect; 2023 Jun; 29(6):781-788. PubMed ID: 36736662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():980711. PubMed ID: 36875134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
    Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of BCG Revaccination With
    Dos Anjos LRB; da Costa AC; Cardoso ADRO; Guimarães RA; Rodrigues RL; Ribeiro KM; Borges KCM; Carvalho ACO; Dias CIS; Rezende AO; Souza CC; Ferreira RRM; Saraiva G; Barbosa LCS; Vieira TDS; Conte MB; Rabahi MF; Kipnis A; Junqueira-Kipnis AP
    Front Immunol; 2022; 13():841868. PubMed ID: 35392074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic.
    Moorlag SJCFM; Taks E; Ten Doesschate T; van der Vaart TW; Janssen AB; Müller L; Ostermann P; Dijkstra H; Lemmers H; Simonetti E; Mazur M; Schaal H; Ter Heine R; van de Veerdonk FL; Bleeker-Rovers CP; van Crevel R; Ten Oever J; de Jonge MI; Bonten MJ; van Werkhoven CH; Netea MG
    Clin Infect Dis; 2022 Aug; 75(1):e938-e946. PubMed ID: 35247264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
    Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
    Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
    Pittet LF; Messina NL; Orsini F; Moore CL; Abruzzo V; Barry S; Bonnici R; Bonten M; Campbell J; Croda J; Dalcolmo M; Gardiner K; Gell G; Germano S; Gomes-Silva A; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Lacerda MVG; Lee KJ; Lucas M; Lynn DJ; Manning L; Marshall HS; McDonald E; Munns CF; Nicholson S; O'Connell A; de Oliveira RD; Perlen S; Perrett KP; Prat-Aymerich C; Richmond PC; Rodriguez-Baño J; Dos Santos G; da Silva PV; Teo JW; Villanueva P; Warris A; Wood NJ; Davidson A; Curtis N;
    N Engl J Med; 2023 Apr; 388(17):1582-1596. PubMed ID: 37099341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes.
    Faustman DL; Lee A; Hostetter ER; Aristarkhova A; Ng NC; Shpilsky GF; Tran L; Wolfe G; Takahashi H; Dias HF; Braley J; Zheng H; Schoenfeld DA; Kühtreiber WM
    Cell Rep Med; 2022 Sep; 3(9):100728. PubMed ID: 36027906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
    Kumari P; Gupta UD; Bhagyawant SS
    Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/
    Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS
    Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.